Huntingtin-deficient zebrafish exhibit defects in iron utilization and development

被引:113
作者
Lumsden, Amanda L. [1 ]
Henshall, Tanya L. [1 ]
Dayan, Sonia [1 ]
Lardelli, Michael T. [1 ]
Richards, Robert I. [1 ]
机构
[1] Univ Adelaide, ARC Special Res Ctr, Sch Mol & Biomed Sci, Mol Genet Dev & Discipline Genet, Adelaide, SA 5005, Australia
关键词
D O I
10.1093/hmg/ddm138
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Huntington's disease (HD) is one of nine neurodegenerative disorders caused by expansion of CAG repeats encoding polyglutamine in their respective, otherwise apparently unrelated proteins. Despite these proteins having widespread and overlapping expression patterns in the brain, a specific and unique subset of neurons exhibits particular vulnerability in each disease. It has been hypothesized that perturbation of normal protein function contributes to the specificity of neuronal vulnerability; however, the normal biological functions of many of these proteins including the HD gene product, Huntingtin (Htt), are unclear. To explore the roles of Htt, we have used antisense morpholino oligonucleotides to observe the effects of Htt deficiency in early zebrafish development. Knockdown of Htt expression resulted in a variety of developmental defects. Most notably, Htt-deficient zebrafish had hypochromic blood due to decreased hemoglobin production, despite the presence of iron within blood cells. Furthermore, transferrin receptor 1 transcripts were increased, suggesting cellular iron starvation. Provision of iron to the cytoplasm in a bio-available form restored hemoglobin production in Htt-deficient embryos. Since erythroid cells acquire iron via receptor-mediated endocytosis of transferrin, these results suggest a role for Htt in making endocytosed iron accessible for cellular utilization. Iron is required for oxidative energy production, and defects in iron homeostasis and energy metabolism are features of HD pathogenesis that are most pronounced in the major region of neurodegeneration. It is therefore plausible that perturbation of Htt's normal role in the iron pathway (by polyglutamine tract expansion) contributes to HD pathology, and particularly to its neuronal specificity.
引用
收藏
页码:1905 / 1920
页数:16
相关论文
共 117 条
[1]   Chemistry and biology of eukaryotic iron metabolism [J].
Aisen, P ;
Enns, C ;
Wessling-Resnick, M .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2001, 33 (10) :940-959
[2]   STRUCTURE AND EXPRESSION OF THE HUNTINGTONS-DISEASE GENE - EVIDENCE AGAINST SIMPLE INACTIVATION DUE TO AN EXPANDED CAG REPEAT [J].
AMBROSE, CM ;
DUYAO, MP ;
BARNES, G ;
BATES, GP ;
LIN, CS ;
SRINIDHI, J ;
BAXENDALE, S ;
HUMMERICH, H ;
LEHRACH, H ;
ALTHERR, M ;
WASMUTH, J ;
BUCKLER, A ;
CHURCH, D ;
HOUSMAN, D ;
BERKS, M ;
MICKLEM, G ;
DURBIN, R ;
DODGE, A ;
READ, A ;
GUSELLA, J ;
MACDONALD, ME .
SOMATIC CELL AND MOLECULAR GENETICS, 1994, 20 (01) :27-38
[3]   Identification of 315 genes essential for early zebrafish development [J].
Amsterdam, A ;
Nissen, RM ;
Sun, ZX ;
Swindell, EC ;
Farrington, S ;
Hopkins, N .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (35) :12792-12797
[4]   Striatal glucose metabolism and dopamine D-2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease [J].
Antonini, A ;
Leenders, KL ;
Spiegel, R ;
Meier, D ;
Vontobel, P ;
WeigellWeber, M ;
SanchezPernaute, R ;
deYebenez, JG ;
Boesiger, P ;
Weindl, A ;
Maguire, RP .
BRAIN, 1996, 119 :2085-2095
[5]   Complex I defect in muscle from patients with Huntington's disease [J].
Arenas, J ;
Campos, Y ;
Ribacoba, R ;
Martín, MA ;
Rubio, JC ;
Ablanedo, P ;
Cabello, A .
ANNALS OF NEUROLOGY, 1998, 43 (03) :397-400
[6]   Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death [J].
Arrasate, M ;
Mitra, S ;
Schweitzer, ES ;
Segal, MR ;
Finkbeiner, S .
NATURE, 2004, 431 (7010) :805-810
[7]   The role of heme and iron-sulfur clusters in mitochondrial biogenesis, maintenance, and decay with age [J].
Atamna, H ;
Walter, PB ;
Ames, BN .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 397 (02) :345-353
[8]  
Bartzokis G, 2000, CELL MOL BIOL, V46, P821
[9]   Increased basal ganglia iron levels in Huntington disease [J].
Bartzokis, G ;
Cummings, J ;
Perlman, S ;
Hance, DB ;
Mintz, J .
ARCHIVES OF NEUROLOGY, 1999, 56 (05) :569-574
[10]  
BEAL MF, 1994, NEUROBIOL AGING, V15, P275